期刊文献+

5-杂氮-2′-脱氧胞苷降低了乳腺癌MDA-MB-231细胞的体外迁移能力 被引量:2

5-Aza-2′-deoxycytidine decreases migration ability of breast cancer MDA-MB-231 cells in vitro
下载PDF
导出
摘要 目的探讨5-杂氮-2′-脱氧胞苷(5-Aza-CdR)对高转移性人乳腺癌MDA-MB-231细胞体外迁移能力的作用及可能的机制。方法实验分为对照组与5-Aza-CdR处理组,分别通过Transwell趋化迁移及划痕实验、半定量逆转录PCR(SqRT-PCR)、甲基化特异性PCR(MSP)等方法检测MDA-MB-231细胞的体外迁移能力、乳腺癌转移抑制基因-1(BRMS1)与CXC趋化因子受体-4(CXCR4)基因表达、BRMS1与CXCR4启动子区甲基化状况。结果对照组与处理组细胞穿过Transwell聚碳酸酯滤膜的数量分别为1 290.00±214.64与673.00±44.00,处理组细胞穿膜数量明显减少(P<0.05);24、36、48 h时间点对照组与处理组细胞划痕愈合率分别为20.34±0.69、59.31±0.38、91.77±0.13与20.19±0.67、49.32±0.24、69.47±0.46,其中36 h与48 h时间点处理组愈合率明显降低(P<0.05);对照组与处理组BRMS1的相对于内参GAPDH的灰度值(IDV)分别为0与0.39±0.001,处理组BRMS1 mRNA表达明显上调(P<0.05),5-Aza-CdR使BRMS1启动子区甲基化的CpG岛B完全去甲基化,对照组与处理组CXCR4的相对于内参GAPDH的IDV分别为0.58±0.003与0.58±0.01,两组比较差异无统计学意义(P>0.05),CXCR4启动子区CpG岛1的非甲基化状态亦无明显改变。结论 5-Aza-CdR通过去甲基化机制重新激活肿瘤转移抑制基因BRMS1的表达,从而降低了MDA-MB-231细胞体外迁移能力。 Objective To investigate the migration function of 5-Aza-CdR on high metastatic human breast cancer MDA-MB-231 cell line in vitro and possible mechanisms.Methods MDA-MB-231 cells were treated with 5-Aza-CdR,then cell migration ability in vitro,the mRNA expressions and promotor methylation status of breast cancer metastasis suppressor-1(BRMS1) gene and C-X-C chemokine receptor-4(CXCR4)gene were detected by Transwell chemotactic migration and wound closure assay,semi-quantitative reverse transcription-PCR(SqRT-PCR),methylation-specific polymerase chain reaction(MSP) respectively.Results 5-Aza-CdR decreased the number of cells passing through polycarbonate filter membrane(1290.00±214.64 versus 673.00±44.00,P0.05)and the rate of wound closure(20.34±0.69,59.31±0.38,91.77±0.13 versus 20.19±0.67,49.32±0.24,69.47±0.46 at 24h,36h,48h time points respetively)at 36h,48h time points(P0.05);upgraded the BRMS1 mRNA expression(0 versus 0.39±0.001(relative integrated density value,IDV against GAPDH),P0.05) and demethylated the methylated CpG island B in promotor,while the CXCR4 mRNA expression(0.58±0.003 versus 0.58±0.01,P0.05) and the status of unmethylated CXCR4 CpG island 1 in promotor were not changed significantly.Conclusion 5-Aza-CdR reactivates tumor metastasis suppressor gene BRMS1 and decreases the migration ability of MDA-MB-231 cells in vitro by demethylation mechanism.
出处 《重庆医学》 CAS CSCD 北大核心 2010年第10期1209-1211,共3页 Chongqing medicine
基金 广东省科技计划项目(2008B030301345)
  • 相关文献

参考文献10

  • 1Ehrlich M.DNA methylation in cancer:too much,but also too little[J].Oncogene,2002,21(35):5400.
  • 2Mulero-Navarro S,Esteller M.Epigenetic biomarkers for human cancer:the time is now[J].Crit Rev Oncol Hematol,2008,68(1):1.
  • 3Abreu PA,Dellamora-Ortiz G,Leao-Ferreira LR,et al.DNA methylation:a promising target for the twenty-first century[J].Expert Opin Ther Targets,2008,12(8):1035.
  • 4Szyf M,Pakneshan P,Rabbani SA.DNA methylation and breast cancer[J].Biochem Pharmacol,2004,68(6):1187.
  • 5Metge BJ,Frost AR,King JA,et al.Epigenetic silencing contributes to the loss of BRMS1 expression in breast cancer[J].Clin Exp Metastasis,2008,25(7):753.
  • 6Bogani C,Ponziani V,Guglielmelli P,et al.Hypermethylation of CXCR4 promoter in CD34+ cells from patients with primary myelofibrosis[J].Stem Cells,2008,26(8):1920.
  • 7Samant RS,Clark DW,Fillmore RA,et al.Breast cancer metastasis suppressor 1(BRMS1) inhibits osteopontin transcription by abrogating NF-kappaB activation[J].Mol Cancer,2007,6:6.
  • 8Phadke PA,Vaidya KS,Nash KT,et al.BRMS1 suppresses breast cancer experimental metastasis to multiple organs by inhibiting several steps of the metastatic process[J].Am J Pathol,2008,172(3):809.
  • 9Muller A, Homey B,Soto H,et al. Involvement of chemokine receptors in breast cancer metastasis[J]. Nature, 2001,410 (6824) : 50.
  • 10Helbig G, Christopherson KN, Bhat-Nakshatri P, et al. NF-kappaB promotes breast cancer cell migration and metastasis by inducing the expression of the chemokine receptor CXCR4[J]. J Biol Chem,2003,278(24):21631.

同被引文献25

  • 1王栋,郭满盈,郭葆玉.趋化因子受体5在乳腺浸润性导管癌组织的表达及意义[J].第二军医大学学报,2005,26(6):657-659. 被引量:14
  • 2范江,陆劲松,王磊,吴炅,侯意枫,李大强,狄根红,沈镇宙,邵志敏.5-aza-2’deoxycytidine联合trichostatin A抑制乳腺癌细胞增殖能力的研究[J].中国癌症杂志,2006,16(5):329-332. 被引量:4
  • 3姚晓莉,童鹤翔,涂毅,姚峰,王卫星,孙圣荣.CCL5及其受体在乳腺癌组织中的表达及其意义[J].中华实验外科杂志,2007,24(5):590-592. 被引量:15
  • 4Muller A,Homey B,Soto H,et al.Involvement of chemokine receptors in breast cancer metastasis[J].Nature,2001,410(6824):50-56.
  • 5Andre1 F,Cabioglu N,Assi1 H,et al.Expression of chemokine receptors predicts the site of metastatic relapse in patients with axillary node positive primary breast cancer[J].Ann Oncol,2006,17(6):945-951.
  • 6郭满盈,陈扬,吴林松,杨海燕.乳腺癌组织趋化因子受体CXCR4的表达与意义[J].国际检验医学杂志,2007,28(10):888-889. 被引量:6
  • 7Christman JK. 5-Azacytidine and 5 -aza-2 , -deoxycytidine asinhibitors of DNA methylation : mechanistic studies and theirimplications for cancer therapy [ J]. Oncogene,2002 ,21 (35 ):5483-5495.
  • 8Momparler RL. Epigenetic therapy of cancer with 5-aza-2 , -deoxycytidine (decitabine) [ J]. Semin Oncol,2005,32 (5 ):443451.
  • 9Chen J, Feng XH, Shi J, et al. The anti-nociceptive effect ofBmK AS, a scorpion active polypeptide, and the possiblemechanism on specifically modulating voltage-gated Na+ currentsin primary afferent neurons[J]. Peptides,2006,27(9) :2182-2192.
  • 10Cleator S, Heller W, Coombes RC. Triple-negative breastcancer : therapeutic options [ J]. Lancet Oncol,2007 ,8(3):235-244.

引证文献2

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部